Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian E Antoni

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Arthritis Research & Therapy|July 2, 2004
Treating psoriatic arthritis: how effective are TNF antagonists?Alice B Gottlieb, Christian E Antoni
The Journal of Rheumatology|February 17, 2010
Standardization of joint examination technique leads to a significant decrease in variability among different examinersMathias Grunke, Christian E Antoni, Arthur Kavanaugh, et al.
Clinical Rheumatology|March 20, 2008
An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody statusArie E van der Bijl, Ferdinand C Breedveld, Christian E Antoni, et al.
Arthritis and Rheumatism|April 9, 2005
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Bruce Kirkham, et al.
The Journal of Rheumatology|April 3, 2008
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Désirée van der Heijde, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Arthritis Research & Therapy|July 2, 2004
Treating psoriatic arthritis: how effective are TNF antagonists?Alice B Gottlieb, Christian E Antoni
The Journal of Rheumatology|February 17, 2010
Standardization of joint examination technique leads to a significant decrease in variability among different examinersMathias Grunke, Christian E Antoni, Arthur Kavanaugh, et al.
Clinical Rheumatology|March 20, 2008
An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody statusArie E van der Bijl, Ferdinand C Breedveld, Christian E Antoni, et al.
Arthritis and Rheumatism|April 9, 2005
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Bruce Kirkham, et al.
The Journal of Rheumatology|April 3, 2008
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Désirée van der Heijde, et al.
Pageof 1